Letters to the Editor

Naltrexone

Gennaro D'Alesandro
  • 1 October 1999
Experimental and Clinical Pharmacology

Assessing the statins

Eve Hurley
  • 1 October 1999
Experimental and Clinical Pharmacology

St. John's wort - quack medicine or novel antidepressant treatment?

Philip B. Mitchell
  • 1 October 1999
Letters to the Editor

Primaquine phosphate

Avijit Hazra
  • 1 October 1999
Experimental and Clinical Pharmacology

The new antidepressants - mechanisms of action

Trevor R. Norman
  • 1 October 1999
Letters to the Editor

Post-traumatic stress disorder

Maarten de Vries MDV Leadership and Management Ashgrove, Qld, Mark Creamer, Alexander McFarlane, Tuly Rosenfeld, Graham Vimpani
  • 1 October 1999
Experimental and Clinical Pharmacology

The new antidepressants - clinical applications

John W.G. Tiller
  • 1 October 1999
Letters to the Editor

Warfarin therapy

Leslie E. Bolitho
  • 1 October 1999
Experimental and Clinical Pharmacology

Common questions about the management of meningococcal disease

  • 1 October 1999
Article

Topical anal preparations

John Cartmill
  • 1 October 1999
Top 10 drugs

Top 10 drugs

  • 1 October 1999
NEW DRUGS
Nadroparin calcium
  • 1 October 1999
Dicloxacillin
  • 1 October 1999
Dipyridamole
  • 1 October 1999
Palivizumab
  • 1 October 1999
Abacavir
  • 1 October 1999
Grepafloxacin
  • 1 October 1999
Indapamide hemihydrate
  • 1 October 1999
Mometasone furoate
  • 1 October 1999
Doxycycline hydrochloride
  • 1 October 1999
Aciclovir
  • 1 October 1999
Fluticasone propionate
  • 1 October 1999
Oxycodone hydrochloride
  • 1 October 1999
Epoetin alfa (rch)
  • 1 October 1999
Lamivudine
  • 1 October 1999

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe